Nam Nivanna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nam Nivanna has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Kazuko Kimura
Medi-Quality Security Institute, Graduate School of Medical Sciences, Kanazawa University, Kakuma-Machi, Kanazawa 920-1192, Japan
3 shared publications - Mohiuddin Hussain Khan
Drug Management and Policy, Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan
3 shared publications - Naoko Yoshida
AI Hospital/Macro Signal Dynamics Research and Development Center, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University
3 shared publications - Tey Sovannarith
National Health Product Quality Control Center, Ministry of Health, Phnom Penh, Cambodia
3 shared publications - Eav Dararath
Department of Drugs and Food, Ministry of Health, 151-153, Kampuchea Krom St, Khan 7 Makara, Phnom Penh, Cambodia
2 shared publications - Heng Bun Kiet
Department of Drugs and Food, Ministry of Health, Phnom Penh, Cambodia
2 shared publications
Latest Publications
- Open Access
- 5 March 2014
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 15 (1) , 13
A cross-sectional investigation of the quality of selected medicines in Cambodia in 2010
Access to good-quality medicines in many countries is largely hindered by the rampant circulation of spurious/falsely labeled/falsified/counterfeit (SFFC) and substandard medicines. In 2006, the Ministry of Health of Cambodia, in collaboration with Kanazawa University, Japan, initiated a project to combat SFFC medicines.
- 5 March 2014
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 15 (1) , 13
Open AccessA cross-sectional investigation of the quality of selected medicines in Cambodia in 2010
Access to good-quality medicines in many countries is largely hindered by the rampant circulation of spurious/falsely labeled/falsified/counterfeit (SFFC) and substandard medicines. In 2006, the Ministry of Health of Cambodia, in collaboration with Kanazawa University, Japan, initiated a project to combat SFFC medicines.
- Open Access
- 18 June 2013
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 14 (1) , 33
Effects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid – an analysis of Cambodian samples
The use of substandard and degraded medicines is a major public health problem in developing countries such as Cambodia. A collaborative study was conducted to evaluate the quality of amoxicillin–clavulanic acid preparations under tropical conditions in a developing country. Amoxicillin-clavulanic acid tablets were obtained from outlets in Cambodia. Packaging condition, printed information, and other sources of information were examined. The samples were tested for quantity, content uniformity, and dissolution. Authenticity was verified with manufacturers and regulatory authorities. A total of 59 samples were collected from 48 medicine outlets. Most (93.2%) of the samples were of foreign origin. Using predetermined acceptance criteria, 12 samples (20.3%) were non-compliant. Eight (13.6%), 10 (16.9%), and 20 (33.9%) samples failed quantity, content uniformity, and dissolution tests, respectively. Samples that violated our observational acceptance criteria were significantly more likely to fail the quality tests (Fisher’s exact test, p < 0.05). Improper packaging and storage conditions may reduce the quality of amoxicillin–clavulanic acid preparations at community pharmacies. Strict quality control measures are urgently needed to maintain the quality of amoxicillin–clavulanic acid in tropical countries.
- 18 June 2013
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 14 (1) , 33
Open AccessEffects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid – an analysis of Cambodian samples
The use of substandard and degraded medicines is a major public health problem in developing countries such as Cambodia. A collaborative study was conducted to evaluate the quality of amoxicillin–clavulanic acid preparations under tropical conditions in a developing country. Amoxicillin-clavulanic acid tablets were obtained from outlets in Cambodia. Packaging condition, printed information, and other sources of information were examined. The samples were tested for quantity, content uniformity, and dissolution. Authenticity was verified with manufacturers and regulatory authorities. A total of 59 samples were collected from 48 medicine outlets. Most (93.2%) of the samples were of foreign origin. Using predetermined acceptance criteria, 12 samples (20.3%) were non-compliant. Eight (13.6%), 10 (16.9%), and 20 (33.9%) samples failed quantity, content uniformity, and dissolution tests, respectively. Samples that violated our observational acceptance criteria were significantly more likely to fail the quality tests (Fisher’s exact test, p < 0.05). Improper packaging and storage conditions may reduce the quality of amoxicillin–clavulanic acid preparations at community pharmacies. Strict quality control measures are urgently needed to maintain the quality of amoxicillin–clavulanic acid in tropical countries.
- Open Access
- 11 November 2011
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 306
Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey
Recent investigations by the Ministry of Health of Cambodia suggest that counterfeit medicines have been introduced into the pharmaceutical market in tampered packaging. To further explore this possibility, an interview survey was conducted at the wholesaler level to investigate the medicinal supply chain in Cambodia.
- 11 November 2011
- Published by Springer Nature in BMC Health Services Research
- Vol. 11 (1) , 306
Open AccessPerceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey
Recent investigations by the Ministry of Health of Cambodia suggest that counterfeit medicines have been introduced into the pharmaceutical market in tampered packaging. To further explore this possibility, an interview survey was conducted at the wholesaler level to investigate the medicinal supply chain in Cambodia.